logo
Select company
Select metric
68.39%Cash to Assets Ratio
VS
Market
95
Sector
82
Industry
90
History
-
$ 5.69Close
$ 3.04 - $ 25.83 52-Week Range
Ticker Information

Ticker

BIOA

Company Name

BIOAGE LABS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

BIOAGE LABS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BIOA - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 322.15M$ 220.33M68.39%
3/31/2025$ 343.84M$ 257.49M74.89%
12/31/2024$ 358.23M$ 354.35M98.92%
9/30/2024$ 337.38M$ 334.47M99.14%
6/30/2024$ 164.4M$ 159.09M96.77%
12/31/2023$ 25.92M$ 24.96M96.27%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOAGE LABS INC's latest trailing twelve months (TTM) Cash to Assets stands at 96.27%.
  • Over the past 5 years, BIOAGE LABS INC's average Cash to Assets has been 89.06%.
  • The median Cash to Assets for BIOAGE LABS INC during this period was 96.52%
  • BIOAGE LABS INC reached its highest Cash to Assets over the past 5 years at 99.14%.
  • The lowest Cash to Assets recorded by BIOAGE LABS INC in the same timeframe 68.39%

BIOAGE LABS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
OBIO : ORCHESTRA BIOMED HOLDINGS INC 43.78%SCYX : SCYNEXIS INC 18.56%ACOG : ALPHA COGNITION INC 87.46%LUCD : LUCID DIAGNOSTICS INC 80.48%CPHI : CHINA PHARMA HOLDINGS INC 4.54%ARMP : ARMATA PHARMACEUTICALS INC 12.03%IXHL : INCANNEX HEALTHCARE INC 73.55%AVR : ANTERIS TECHNOLOGIES GLOBAL CORP 71.31%CTOR : CITIUS ONCOLOGY INC 0%IMDX : INSIGHT MOLECULAR DIAGNOSTICS INC 51.44%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for BIOAGE LABS INC is calculated as follows: CashnEq [ $ 24.96M ] / Assets [ $ 25.92M ]
(=) Cash to Assets [ 96.27% ]

BIOA - Cash to Assets Ratio, Last 5 years

68.39%

Minimum

Jun 30, 2025

99.14%

Maximum

Sep 30, 2024

89.06%

Average

96.52%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.79% with a standard deviation of 9.55%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.8%
average9.79%
median6.44%
std9.55%